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Key points 
 
- Wave travel plays an important role in cardiovascular physiology. However, many aspects 
of pulmonary arterial wave behaviour remain unclear 
- Wave intensity and reservoir-excess pressure analyses were applied in the pulmonary artery 
in subjects with and without pulmonary hypertension during spontaneous respiration and 
dynamic stress tests. 
- Arterial wave energy decreased during expiration and Valsalva manoeuvre due to decreased 
ventricular preload. Wave energy also decreased during handgrip exercise due to increased 
heart rate. 
- In pulmonary hypertension patients, the asymptotic pressure at which the microvascular 
flow ceases, the reservoir pressure related to arterial compliance and the excess pressure 
caused by waves increased. The reservoir and excess pressures decreased during Valsalva 
manoeuvre but remained unchanged during handgrip exercise.  
- This study provides insights into the influence of pulmonary vascular disease, spontaneous 
respiration and dynamic stress tests on pulmonary artery wave propagation and reservoir 
function.  
 
  
Abstract 
 
Detailed hemodynamic analysis may provide novel insights into the pulmonary circulation. 
Therefore, wave intensity and reservoir-excess pressure analyses were applied in the pulmonary 
artery to characterise changes in wave propagation and reservoir function during spontaneous 
respiration and dynamic stress tests. Right heart catheterisation was performed using a pressure and 
Doppler flow sensor tipped guidewire to obtain simultaneous pressure and flow velocity 
measurements in the pulmonary artery in control subjects and patients with pulmonary arterial 
hypertension (PAH) at rest. In controls, recordings were also obtained during Valsalva manoeuvre 
and handgrip exercise. The asymptotic pressure at which the flow through the microcirculation 
ceases, the reservoir pressure related to arterial compliance and the excess pressure caused by 
arterial waves increased in PAH patients compared to controls. The systolic and diastolic rate 
constants also increased, while the diastolic time constant decreased. The forward compression 
wave energy decreased by 6 % in controls and 5 % in PAH patients during expiration compared 
to inspiration, while the wave speed remained unchanged throughout the respiratory cycle. Wave 
energy decreased during Valsalva manoeuvre (by 50 %) and handgrip exercise (by 27 %) with 
unaffected wave speed. Moreover, the reservoir and excess pressures decreased during Valsalva 
manoeuvre but remained unaltered during handgrip exercise. In conclusion, reservoir-excess 
pressure analysis applied to the pulmonary artery revealed distinctive differences between controls 
and PAH patients. Variations in the ventricular preload and afterload influence pulmonary arterial 
wave propagation as demonstrated by changes in wave energy during spontaneous respiration and 
dynamic stress tests.   
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 Introduction 
 
Wave propagation and Windkessel models are widely used to describe the arterial system. In 1-
dimensional wave propagation models, the artery is envisaged as an elastic tube, where travelling 
waves occur. The speed at which the wave travels through the arterial tree is a surrogate marker for 
arterial stiffness. Wave intensity analysis (WIA) (Parker, 2009;Su et al., 2016) is an investigative 
tool that uses simultaneous changes in the arterial pressure and flow velocity to determine the 
intensity, origin, type and timing of the arterial waves. Four types of arterial waves are described: 
forward waves are generated by upstream events, e.g. related to the ventricle (and reflections of 
backward waves) and can be a forward compression wave (FCW) that increases the pressure and 
flow or a forward decompression wave (FDW) that decreases the pressure and flow. Similarly, 
backward waves are generated by downstream properties and can be a backward compression wave 
(BCW) that increases the pressure while decreasing the flow or a backward decompression wave 
(BDW) that decreases the pressure while increasing the flow.  
In the Windkessel model, large elastic arteries are modelled as a single compliant compartment. 
When the ventricle ejects blood into this compartment, arterial inflow temporarily exceeds outflow 
leading to increased compartmental volume, the reservoir volume, and the reservoir pressure is the 
pressure that has to build up to store the reservoir volume. The Windkessel model is a simple model 
that is easy to understand, but cannot take account of wave phenomena. More recently, a model 
which incorporates features of the Windkessel model with the wave propagation model has been 
developed (Wang et al., 2003) and after modification has been termed the reservoir-excess pressure 
model (Parker, 2013).   
In recent years, there is an increasing interest in the role of travelling waves in arterial physiology 
and pathophysiology. For instance, WIA applied in animal models has provided novel insights into 
the arterial properties of the adult and fetal pulmonary circulation (Hollander et al., 2004;Smolich et 
al., 2008). Recently, several studies have explored the usefulness of WIA in pulmonary 
hypertension (defined as a mean pulmonary arterial pressure, PAPm  25 mmHg) (Lau et al., 
2014;Quail et al., 2015) (Su et al. 2017, submitted). However, there are still many aspects of wave 
propagation in the pulmonary artery that remain unclear. The objective of this study was to employ 
WIA and reservoir-excess pressure analysis in the pulmonary artery in subjects with and without 
pulmonary arterial hypertension (PAH) to characterise wave propagation and reservoir function 
during spontaneous respiration and dynamic stress tests in the forms of Valsalva manoeuvre and 
handgrip exercise.  
 
Methods 
 
Ethical approval 
 
    Control subjects were selected among patients that were referred for coronary angiography or 
electrophysiology procedures for supraventricular tachycardias. Patients without significant 
cardiovascular or lung diseases that had unobstructed coronary arteries on the angiogram and 
normal biventricular dimensions and function without significant valvular pathology as assessed by 
transthoracic echocardiography were included as controls. PAH patients were recruited from the 
National Pulmonary Hypertension Service. The study conformed to the Declaration of Helsinki and 
was approved by the London-Fulham Research Ethics Committee (reference 13/LO/1305) and all of 
the subjects gave written informed consent. 
 
Study protocol 
 
All patients were in sinus rhythm at the time of investigation. Right heart catheterisation was 
performed by advancing a 6 Fr multipurpose catheter or a 6 Fr balloon flotation catheter into either 
the left or right pulmonary artery via the right femoral or brachial vein. A combined dual-tipped 
pressure and Doppler flow sensor wire (Combowire, Philips Volcano, California, USA) was then 
advanced approximately 1 cm beyond the end of the catheter (Su et al. 2017, submitted). Careful 
manipulation of the catheter and wire ensured that the Doppler flow velocity signals were optimized 
in situ. Once stable signals were observed, pressure and velocity data were acquired simultaneously 
(Combomap, Philips Volcano) at a sampling rate of 200 Hz for 30 – 60 seconds together with ECG 
monitoring in free breathing state. Subsequently, the control subjects were asked to perform a 
modified Valsalva Manoeuvre by exhaling against a custom-designed pressure device to maintain a 
target pressure of 30 mmHg for 10 – 15 seconds. After returning to resting condition, the recordings 
were made for 20 seconds during submaximal (50 %) isometric handgrip exercise. Cardiac output at 
rest was determined by direct Fick method. If direct measurement was not possible, the indirect 
Fick method was used. 
 
Wave intensity analysis 
  
WIA was performed using custom-written Matlab software (MathWorks, Massachusetts, USA). 
Pressure and velocity signals were ensemble-averaged by an automated process using the R-wave 
on the ECG as a fiducial marker. The signals were smoothed and the 1st derivative of the data was 
calculated using a Savitzky-Golay differentiating filter (2nd order polynomial fit, window size 11). 
Hardware-related delay between pressure and velocity signals was corrected by shifting the velocity 
data until the beginning of the upslope of the velocity and pressure waveforms were aligned (Su et 
al., 2017, submitted). 
The net wave intensity is the product of the measured change in pressure and velocity and 
describes the rate of wave energy flux per cross sectional area of the artery. It is positive for 
forward travelling waves and negative for backward travelling waves. The local wave speed (c) was 
calculated using the sum of squares method (equation 1) (Davies et al., 2006). 
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where  is the blood density, assumed to be 1040 kg/m3 and the sum is taken over one cardiac 
period. 
    The original dimension of wave intensity depends on the sampling time of data acquisition and 
therefore, “time-normalized” wave intensity calculated using the derivatives of pressure and 
velocity was derived (Parker, 2009). However, the resulting dimension for the time-normalized 
value (Wm-2s-2) does not have a straightforward physiological meaning. To circumvent this 
problem, here, wave intensity (WI) was normalized to the number of samples squared in the cardiac 
cycle. Given that analyses were performed on complete cardiac cycles, this is a more “natural” 
normalization than time normalization; however it is simple to convert between time- and cycle-
normalized units, if required, using the duration of the cardiac cycle. Separation of waves into their 
forward (WI+) and backward (WI-) components was performed (equation 2). 
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where CCD is the duration of the cardiac cycle.  
To assess the respiratory variation, cardiac beats were identified as inspiratory or expiratory 
(Figure 1) based on their temporal relationship to the ECG-derived respiratory signals (Widjaja et 
al., 2010) and/or the respiratory variation in pulmonary pressure (Brecher & Hubay, 1955). Pressure 
and velocity data were ensemble-averaged over the two respiratory periods and WIA was 
performed as described above. The differences in the ensemble-averaging step, i.e. automated 
process versus manual beat selection could lead to a slight discrepancy in the wave intensity and 
reservoir parameters between free breathing state and the corresponding inspiratory and expiratory 
values.  
Separated waves were quantified by the cumulative area under each wave corresponding to the 
wave energy per cross sectional area of the artery, over a cardiac period squared. The ratio of 
backward wave to FCW energy is denoted as the wave reflection index (WRI). The ejection period 
was taken as the interval between the start of FCW to the end of FDW in systole. 
 
Reservoir-excess pressure analysis 
 
    The reservoir pressure was calculated from the raw pressure data using previously described 
formula (Aguado-Sierra et al., 2008).  
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The reservoir pressure (Pr) is determined by the resistance (R) to outflow from the reservoir, the 
reservoir compliance (C) and the asymptotic pressure (P).  P is the limit for the exponential decay 
of reservoir pressure during diastole and corresponds to the pressure at which outflow through the 
microcirculation would be predicted to be zero; this may exceed the pulmonary venous or left atrial 
pressure due to the Starling resistor behaviour of the pulmonary circulation (Graham et al., 1982). ks 
is the rate constant for reservoir filling (systolic rate constant), which, if it is assumed that 
waveforms of excess pressure and flow velocity are identical, can be interpreted as the 
proportionality constant between the arterial inflow and excess pressure. kb is the rate constant for 
reservoir emptying (diastolic rate constant), which is assumed to depend on the compliance of the 
reservoir and the resistance to outflow. The inverse of kb is , the diastolic time constant. P0 is the 
pressure at the time t0 corresponding to the onset of ventricular ejection, i.e. end-diastolic pressure. 
The excess pressure (Px) is calculated as the difference between the measured pressure (P) and the 
reservoir pressure and is related to arterial wave propagation. Reservoir and excess pressures were 
quantified by peak Pr (minus diastolic pressure) and Px and the integral of Pr (minus diastolic 
pressure) and Px, respectively. The ratio of excess to reservoir pressure integral is denoted excess-
reservoir pressure index (ERPI) (Hametner et al., 2014). In addition, RCTPR was calculated as the 
product of the total pulmonary resistance (TPR, defined as PAPm divided by cardiac output) and 
the global arterial compliance (Cp, defined as the ratio of stroke volume to pulmonary pulse 
pressure) (Lankhaar et al., 2006).  
 
Statistical analysis 
 
     Data were analysed for normality using the quantile-quantile plot. Results are expressed as mean 
(95 % CI)   SD when normally distributed or median (25 % – 75 % quartile), when non-normally 
distributed. Statistical comparisons within the same group were performed using a two-way paired 
Student’s t-test for normally distributed data or Wilcoxon signed-rank test for non-parametric data. 
Differences between the control and PAH group were compared using the unpaired Student’s t-test 
or Welsh’s t-test for unequal variances. Wilcoxon rank-sum test. The correlation between P,  and 
RCTPR was examined using Spearman’s correlation analysis. The level of significance was set at p < 
0.05[JS1]. All statistical analyses were performed using Stata 13 (StataCorp, Texas, USA).  
 
Results 
 
Respiratory variation 
 
The study was carried out in 10 control subjects (59 [49 – 69] yrs 14 yrs, 8 males, PAPm: 17  
3  [15 – 19] mmHg) and 11 PAH patients (56 [95 % CI: 42 – 70]  21 yrs, 2 males, PAPm: 47 [40 – 
54]  11 mmHg). Inspiratory and expiratory data for each of the groups are summarized in Table 1 
and 2, respectively. In both groups, the respiratory variation in heart rate and ejection time did not 
differ significantly. PAPm increased by 4.6 (95 % CI: 3.2 – 6.1)  0.6 mmHg in controls and 6.0 
(95 % CI: 4.9 – 7.1)  0.5 mmHg in PAH patients during expiration compared to inspiration. 
Although not statistically significant, the slightly greater increase in PAPm in PAH patients can be 
attributed to a small, but significant expiratory increase in the pulmonary arterial pulse pressure 
(pPAP, by 0.8  0.3 mmHg), which was not observed in controls. Flow velocity appeared to be 
lower during expiration than inspiration. However, the difference was not statistically significant.  
WIA pattern in the pulmonary artery in health and disease has been described previously (Lau et 
al., 2014). Briefly, a FCW – the incident wave – is observed in early systole corresponding to right 
ventricular (RV) ejection (Figure 2A). This is followed by a FDW in late systole corresponding to 
ventricular relaxation prior to the closure of the pulmonary valve. In control subjects, the energy of 
the mid-systolic backward travelling wave was minimal, while a mid-systolic BCW, i.e. reflection 
of the preceding FCW, of high energy was observed in PAH patients indicative of downstream 
vascular impedance mismatch (Table 3). In both groups, the FCW energy was significantly lower 
during expiration than inspiration (Figure 3) with an expiratory decrease of 8 6 % for controls and 
65 % for PAH patients, respectively. Wave speed, the energy of the backward travelling wave and 
WRI remained unchanged throughout the respiratory cycle in both groups (Table 1 and 2). 
 
Valsalva manoeuvre and handgrip exercise 
 
Pressure and velocity measurements and WIA parameters during dynamic stress tests in controls 
are summarized in Table 3. During Valsalva manoeuvre, PAPm significantly increased by 17 (95 % 
CI: 9 – 24)  10 mmHg while pPAP significantly decreased by 5 (95 % CI: 2  – 7)  3 mmHg 
compared to baseline. Peak velocity was also significantly decreased, while the decrease in mean 
velocity was not statistically significant. During handgrip exercise, the heart rate and PAPm 
significantly increased by 12 (95 % CI: 7 – 17) 7 min-1 and 3 (95 % CI: 1 – 5)  3 mmHg, 
respectively, while the increase in mean velocity was not statistically significant.   
Examples of ensemble-averaged pressure and velocity waveforms and the corresponding WIA 
pattern during Valsalva manoeuvre and handgrip exercise are shown in Figure 2B and 2C, 
respectively. During Valsalva manoeuvre, the ejection period was significantly shorter compared to 
baseline (Table 3). FCW energy significantly reduced by 4550 % during Valsalva manoeuvre and 
27 % during handgrip exercise, respectively, while wave speed and wave reflection did not alter 
significantly. The reduction in wave energy remained statistically significant when non-normalized 
units were examined. The energy of the backward travelling wave was also significantly reduced in 
both tests, while WRI and wave speed did not alter significantly.  
 
Reservoir function 
 
     Recorded pressure waveforms were not suitable for reservoir-excess pressure analysis in two of 
the control subjects and one of the PAH patients. Figure 4 illustrates the reservoir-excess pressure 
model and the separation of the measured pressure into a reservoir and an excess pressure in a 
representative control subject and PAH patient. The reservoir pressure is the dominant component 
of the measured pressure in diastole, while the excess pressure is largely responsible for the early 
systolic pressure rise (Figure 4B and 4C, upper panel). Superimposition of the excess pressure 
waveform onto the velocity waveform showed the similarity of the two waveforms in the control 
subject; whereas the excess pressure waveform had a broad top in comparison to the narrow peak of 
the velocity waveform in the PAH patient (Figure 4B and 4C, lower panel). 
In PAH patients, the peak and integral of Pr and Px were significantly higher compared to 
controls (Table 4) and the asymptotic pressure, P, was 25 mmHg greater. The ratio of the excess 
to reservoir pressure integral (ERPI) was lower in PAH patients (58 %) than controls (76 %), but 
the difference was not statistically significant. The systolic and diastolic rate constants also 
increased significantly. The time constant,, which is the inverse of the diastolic rate constant, was 
therefore significantly decreased in PAH patients. The product of TPR and Cp, RCTPR, was also 
significantly decreased in PAH patients (0.84 [95 % CI: 0.73-0.94] s 0.82 s [0.77 – 1.00 s] versus 
1.09 [0.92 – 1.25] s 1.16 s [0.94 – 1.21 s] in controls). Overall, there is a strong and significant 
correlation between  and RCTPR (Figure 5), while there was no strong association between P and 
RCTPR (controls: rho = -0.36, p = 0.39; PAH: rho = -0.15, p = 0.68) and  (controls: rho = -0.64, p = 
0.09, PAH: rho = -0.36, p = 0.31). 
    There was little respiratory variation in the reservoir function. In the controls, the diastolic rate 
constant significantly decreased in expiration compared to inspiration (Table 1), although the 
difference did not reach statistical signifcance. In PAH patients, the asymptotic pressure and peak Pr 
were significantly higher during expiration compared to inspiration (Table 2).  
During Valsalva manoeuvre, the asymptotic pressure significantly increased by 13 (95 % CI: 1 – 
24)   12 mmHg (Table 4) compared to baseline, while peak Pr and Px significantly decreased 2 
mmHg. Px integral also significantly decreased, while the decrease in Pr integral and ERPI were not 
statistically significant. During handgrip exercise, the diastolic rate constant increased significantly, 
while Tthere were no  significant changes in the other reservoir parameters during handgrip exercise 
(Table 4). 
 
Discussion 
 
By employing WIA and reservoir-excess pressure analysis, the influence of free breathing and 
dynamic stress tests on pulmonary hemodynamics was explored. We observed that 1) arterial wave 
energy was lower during expiration compared to inspiration; 2) arterial wave energy decreased 
during Valsalva Manoeuvre and handgrip exercise; 3) wave speed remained unchanged throughout 
the respiratory cycle and during dynamic stress tests; 4) the asymptotic, reservoir and excess 
pressures as well as the systolic and diastolic rate constants were increased in PAH patients 
compared to controls and; 5) the asymptotic pressure increased and reservoir and excess pressures 
decreased during Valsalva manoeuvre, while they remained unchanged during handgrip exercise.  
 Reservoir, excess and asymptotic pressures 
 
Reservoir-excess pressure analysis has been widely applied in the systemic circulation and 
indices derived from the analysis have been shown to predict cardiovascular events (Davies et al., 
2014;Hametner et al., 2014). However, there are only a limited number of studies exploring the 
reservoir-excess pressure approach in the pulmonary artery in canine models and man 
(Bouwmeester et al., 2013;Bouwmeester et al., 2014;Ghimire et al., 2016).The reservoir-excess 
pressure approach was originally developed using both pressure and flow velocity data (Wang et al., 
2003). Later, a modified approach using pressure data only was developed (Aguado-Sierra et al., 
2008). Both methods produce quantitatively similar results in cases when they have been compared. 
Flow velocity is rarely measured during clinical as well as experimental settings, while pressure 
data is widely available. Therefore, in this study, the reservoir-excess pressure analysis was 
performed using only the measured local pressure data, as this method can be reproduced by most 
investigators. Nevertheless, a systematic comparison of the two methods for calculating reservoir 
pressure is warranted, particularly when there are high intensity wave reflections. However, this is 
beyond the scope of this study. 
Reservoir-excess pressure analysis emphasizes the role of the elastic arteries in storing some part 
of the stroke volume over the cardiac cycle and resolves some apparently anomalous features of 
wave separation in 1-dimensional models (Parker, 2013). Analogous to its systemic counterpart 
(Wang et al., 2003), the work done by the right ventricle (RV) can be interpreted as the sum of the 
work done to fill the reservoir volume and the work done to generate excess pressure (Figure 4A). It 
should be noted that WIA in this study was applied to the measured pressure rather than the 
calculated excess pressure as the validity of WIA using the excess pressure remains controversial 
(Mynard et al., 2012;Segers et al., 2012). As a result of increased RV afterload in PAH, the 
reservoir and excess pressures increased. The close resemblance of the excess pressure waveform 
and the velocity waveform in control subjects is consistent with the low intensity backward 
travelling wave observed using WIA. In PAH patients, however, while the upslope of the excess 
pressure waveform corresponded the upslope of the velocity waveform, the two waveforms 
deviated from one another in mid-systole when the velocity rapidly decreased while peak excess 
pressure was maintained. This is consistent with the large wave reflection evident in WIA.  
It is worth noting that the asymptotic pressure was significantly higher in PAH. P is the pressure 
at which the flow out of the large elastic arteries through the microcirculation would be expected to 
cease. For obvious reasons, P is difficult to determine in man (Schipke et al., 2003) and remains 
predominately an empirical parameter that is used as a fitting parameter in the Windkessel model. 
For simplicity, P  can be set to the venous pressure (Aguado-Sierra et al., 2008;Lankhaar et al., 
2008), which results in a significantly poorer fit to the measured diastolic pressure. Arterial pressure 
at zero flow has been shown to be higher than venous pressure (Magder, 1990), which is generally 
attributed to a Starling-resistor-like effect of the collapsible microcirculatory vessels (Permutt & 
Riley, 1963). This “critical closing pressure” is influenced by the interstitial tissue pressure and the 
active tension generated by vascular smooth muscles (Permutt & Riley, 1963) and it has been 
suggested that the difference between the arterial P and venous P is related to microcirculatory 
resistance. Hence, the high P in PAH may be a consequence of increased vascular tone, rarefaction 
and/or microvascular occlusion (Rabinovitch, 2012).  
 
Systolic and diastolic rate constants 
 
Both the systolic and diastolic rate constants, i.e. the rate of reservoir filling and emptying, were 
significantly increased in PAH patients. The systolic rate constant is the inverse of the product of 
the compliance and the ratio between arterial inflow and excess pressure. This ratio is related to, but 
not necessarily equal to, the characteristic impedance. In PAH, the characteristic impedance has 
been reported to be increased (Haneda et al., 1983;Laskey et al., 1993) and the total arterial 
compliance reduced (Mahapatra et al., 2006). The increased systolic rate constant implies that the 
decrease in compliance is more prominent than the increase in characteristic impedance.  
The diastolic rate constant is the inverse of the diastolic time constant, , which represents the 
exponential reservoir pressure decay during diastole. It describes the relationship between the 
reservoir compliance and the resistance to outflow from the reservoir, i.e. the large pulmonary 
arteries. An average  of 0.240 s in the PAH patients seems quite short. This may be attributed to 
the increase in P, which will result in a decrease of the estimated  (Parragh et al., 2015). RCTPR 
calculated as the product of TPR and total arterial compliance gives a subtly different, but related 
estimate of the diastolic pressure decay. It describes the relationship between the arterial 
compliance and the resistance of the entire pulmonary circulation. Of note, the stroke volume to 
pulse pressure ratio, a simple and commonly used method to calculate arterial compliance, 
overestimates the true compliance as it assumes that the proximal pulmonary arteries form a closed 
system that is exposed to the entire stroke volume without any peripheral outflow (Segers et al., 
1999).  
The RC-time, calculated as the product of vascular resistance (either TPR or pulmonary vascular 
resistance, PVR) and compliance, is a much discussed topic in pulmonary hemodynamics. There is 
evidence that RC-time remains unchanged in individuals with and without pulmonary hypertension 
and during pulmonary hypertension treatment (Lankhaar et al., 2006;Lankhaar et al., 2008), i.e. 
there is a fixed inverse relationship between vascular resistance and compliance. This has been 
interpreted as showing that increased resistance and consequently increased pulmonary pressures 
lead to decreased arterial compliance by a shift in position on the pressure volume relationship as 
the tension from the extensible elastin fibres is transferred to the less extensible collagen fibres 
(London & Pannier, 2010). However, this observation has been contested by several investigators. 
Studies have shown decreased RC-time with increased pulmonary arterial wedge pressure (Tedford 
et al., 2012) and in patients with chronic thromboembolic pulmonary hypertension (MacKenzie 
Ross et al., 2013). Moreover, in a recent study, RC-time has been shown to be increased or 
decreased in PAH patients compared to controls depending on whether PVR or TPR is used to 
derive the value (Hadinnapola et al., 2015). The reported RC-time ranges from 0.21 s (Reuben, 
1971) to 0.95 s (Hadinnapola et al., 2015). The large variation is partly explained by the different 
methods used to derive the value, but also, it challenges the hypothesis of a fixed time constant in 
the pulmonary circulation. In the present study, both  and  RCTPR were lower in PAH patients, 
which is inconsistent with the idea of a fixed relationship between compliance and resistance. The 
decrease in compliance must be more dramatic than the increase in resistance in the PAH patients 
suggesting that arterial wave reflection and perhaps structural changes in the elastic properties of 
the pulmonary artery contribute to increased arterial stiffness in addition to the passive change 
caused by elevated resistance.  
 
Respiratory variations 
  
Respiration has several impacts on the pulmonary circulation; the most evident are changes in 
pulmonary pressures and flow. The pulmonary circulation is exposed to changes in the intrathoracic 
pressure during respiration leading to higher pulmonary arterial pressures during expiration than 
inspiration. The pulmonary flow varies phasically with normal breathing through variations in the 
venous return. During inspiration, the transmural pressure between the right atrium and the pleura 
increases and this is accompanied by an increase in venous return and ventricular stroke volume 
(Brecher & Hubay, 1955) due to the Frank-Starling mechanism. FCW is attributed to RV ejection 
and consequently, its energy is determined by RV preload, contractility and the properties of the 
pulmonary artery. Hence, the FCW energy would be expected to be higher during inspiration than 
expiration in both the control and PAH group as was observed. Moreover, left ventricular 
contractility appears to be greater during inspiration independent of preload (Karlocai et al., 1998). 
However, it is not known whether this also occurs in the right ventricle, but if so it could contribute 
to the larger FCW energy. We did not observe any respiratory variations in pulmonary arterial wave 
speed indicating lack of respiratory variation in the local arterial stiffness. Since wave speed is 
proportional to the characteristic impedance, this is comparable to a previous study that showed no 
change in pulmonary vascular impedance during spontaneous respiration (Murgo & Westerhof, 
1984).  
There was little respiratory variation in the reservoir parameters. In the controls, the diastolic rate 
constant was significantly higher in inspiration compared to expiration. This may be due to a subtle 
decrease in vascular resistance and/or compliance, both of which may vary in relation to changes in 
lung volume during spontaneous respiration and artificial ventilation (Brecher & Hubay, 
1955;Grant et al., 1991;Castiglioni et al., 1996). The respiratory variation in the diastolic rate 
constant was abolished in PAH patients, perhaps because normal respiration exerts minimal impact 
on the high-resistance and low-compliance pulmonary circulation in these patients. In PAH patients, 
the asymptotic pressure was significantly higher during expiration compared to inspiration which 
may be ascribed to the increased intrathoracic pressure consistent with the Starling-resistor theory 
(Permutt & Riley, 1963). The peak reservoir pressure was also increased during expiration, which is 
presumably due to the increased asymptotic pressure rather than changes in arterial compliance.  
 
Impact of Valsalva manoeuvre and handgrip exercise  
 
    We assessed arterial wave behaviour and reservoir function in control subjects during dynamic 
cardiac stress tests by implementing a modified Valsalva manoeuvre and submaximal isometric 
handgrip exercise, which affect the ventricular preload and afterload, respectively. Although not 
routinely used, both manoeuvres have been found to be clinically useful in evaluating 
cardiovascular diseases (Kivowitz et al., 1971;Felker et al., 2006).  
During Valsalva manoeuvre, intrathoracic pressure is increased leading to an increase in the 
systolic, diastolic and mean pulmonary arterial pressures as well as the diastolic asymptotic 
pressure. Although not statistically significant, the 25 % decrease in mean flow velocity implies a 
phase II response to Valsalva manoeuvre (Looga, 2005). In this phase, venous return is impeded by 
compression of the thoracic vena cava and decreased transmural pressure between the right atrium 
and the pleura leading to decreased RV preload and cardiac output. Accordingly, we observed a 
substantial decrease in the ejection duration, FCW energy, pPAP, reservoir pressure and excess 
pressure. The energy of the backward travelling wave reduced accordingly with unchanged WRI. 
Isometric handgrip exercise causes sympathetic nerve activation resulting in a minor increase in 
the heart rate and cardiac output and a pronounced increase in the systemic arterial pressure and 
vascular resistance (Mitchell & Wildenthal, 1974). The hemodynamic effect of handgrip exercise is 
immediate. Within 20 seconds, we observed a 16 % increase in heart rate with a 5 % statistically 
insignificant increase of 5 % in mean flow velocity consistent with a small increase in cardiac 
output. The pulmonary circulation is also subjected to autonomic nervous regulation. Following 
direct sympathetic nerve activation in intact animal models, PVR increases (Kadowitz et al., 1974) 
and arterial compliance decreases (Szidon & Fishman, 1971). Moreover, there is some evidence 
suggesting that PVR may be increased during isometric exercise (White et al., 2013). However, it is 
generally believed that exercise related sympathetic activation causes a balanced -adrenergic 
vasoconstriction and -adrenergic vasodilatation in the pulmonary circulation and therefore exerts 
little net influence on the pulmonary vascular tone (Merkus et al., 2008). Indeed, the ratio of PAPm 
to mean velocity during handgrip exercise was comparable to baseline values indicative of similar 
vascular resistance assuming that the cross sectional area of the artery remained the same. The wave 
speed also remained unchanged suggesting that there was no major change in the local arterial 
stiffness, which is comparable to a recent study using magnetic resonance imaging to derive 
pulmonary arterial wave speed during isometric exercise (Weir-McCall et al., 2016). Consistent 
with the above, the reservoir parameters also remained unchanged. The observed decrease in 
arterial wave energy can be attributed to the increased heart rate and therefore shorter cardiac cycle 
duration as wave energy is expressed over a cardiac period squared in this study (equation 2). The 
shorter cardiac cycle and therefore shorter diastole also results in less ventricular filling which could 
contribute to reduced wave energy.  
 
Study limitations 
 
 The patient number in the present study is small and therefore, some of the statistical 
comparisons may be underpowered and statistically significant effects may be exaggerated. For the 
same reason, we also abstained from performing multivariable analysis and multiple correction 
testing, although failure to use multiple correction testing may potentially lead to an inflated false 
positive rate. To recruit completely healthy control subjects in a catheterization laboratory is not 
feasible. However, we only included individuals without any risk factors for pulmonary vascular 
disease in the form of lung diseases, left ventricular dysfunction or valvular diseases. In addition, 
the majority of the control subjects were male, while the majority of PAH patients were female. 
Although unlikely, we cannot exclude that the uneven distribution in sex may have a small 
influence on the observed differences in wave propagation and reservoir function between the 
control and PAH group.   
Acquiring high quality velocity measurements was technically demanding, especially in PAH 
patients, where the pulmonary flow may be highly disturbed resulting in noises and artefacts in the 
velocity flow signals. Vibration and axial movements of the catheter as well as occasional 
positioning of the catheter against the arterial wall can also introduce signal artefacts. Thus, careful 
manipulation of the catheter during the procedure and meticulous data processing were required. 
We did not use an oesophageal balloon catheter to evaluate the changes in intrapleural pressure 
during free breathing state and Valsalva manoeuvre, nor did we measure pulmonary arterial wedge 
pressure and cardiac output during the dynamic stress tests. Therefore, we could not directly 
determine any variation in the pulmonary distending pressure and PVR under various conditions. 
We did not measure the systemic blood pressure during handgrip exercise. However, the 
hemodynamic effect during handgrip exercise was clear as evidenced by the sudden and significant 
increase in heart rate. The majority of the PAH patients were on PAH-specific therapy and 
therefore, we cannot exclude the influence of pharmacological treatment on wave propagation and 
reservoir function. Furthermore, it would be interesting to investigate the impact of Valsalva 
manoeuvre and handgrip exercise on arterial wave propagation and reservoir function in PAH 
patients in future studies.  
Inspiratory and expiratory cardiac beats were selected based on the respiratory variation in ECG 
signal and pulmonary pressure rather than flow velocity. This may explain why the respiratory 
variation in velocity was statistically insignificant, as variations in the pulmonary flow are most 
apparent in the subsequent cycle in relation to pressure changes. However, we still observed a 
higher mean flow velocity in the selected inspiratory cycles in 70 % of the control subjects and 73 
% of the PAH patients indicative of respiratory variation in pulmonary flow. Lastly, it was not 
possible to perform a satisfactory curve fit in order to carry out the reservoir-excess pressure 
analysis in all the patients because the diastolic pressure waveform could not be described by a 
decreasing exponential as is assumed in the calculation of the reservoir pressure in all the cases.  
 
Conclusions  
 
     This study provides insights into the influence of pulmonary vascular disease, respiration and 
dynamic stress tests on pulmonary artery wave propagation and reservoir function. Consistent with 
increased RV afterload in PAH, the reservoir, excess and asymptotic pressures increased, while the 
diastolic time constant decreased suggestive of intrinsic changes in the pulmonary vasculature. 
Arterial wave energy decreased during expiration and Valsalva manoeuvre as a result of reduced 
RV preload caused by changes in the intrathoracic pressure. Submaximal isometric handgrip 
exercise also caused decreased arterial wave energy in response to shorter cardiac cycles. In 
conclusion, variations in the ventricular preload and afterload alter pulmonary arterial wave 
behaviour and reservoir function.  
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Table 1: Inspiratory and expiratory data for control subjects  
 
 
 
 
 
Results are presented as mean (95 % CI)   SD or median (25 % – 75 % quartile). Abbreviations: 
 Inspiration Expiration p 
Measurements      
Heart rate (min-1) 79 (69-88)  77 (67-86) 0.19 
Ejection time (ms) 360 (332-388) 345 (308-347) 0.09 
Systolic PAP (mmHg) 23 (21-24) 27 (25-30) <0.01* 
Diastolic PAP (mmHg) 9 (8-10) 14 (12-16) <0.01* 
Mean PAP (mmHg) 14 (13-15) 18  (16 -20) <0.01* 
Mean velocity (cms-1) 38.4 (28.5-48.4) 35.7 (27.7-43.8) 0.10 
Max velocity (cms-1) 65.8 (50.6-81.1) 62.7 (47.9-77.6) 0.10 
Wave intensity analysis 
Wave speed (ms-1) 2.40 (1.75-3.05) 2.36 (1.88-2.84) 0.80 
FCW (103 Jm-2) 4.27 (2.89-5.63) 3.92 (2.56-5.29) 0.01* 
FDW (103 Jm-2) 1.62 (0.96-2.28) 1.55 (0.79-2.31) 0.46 
BW (103 Jm-2) 0.22 (0.10-3.37) 0.23 (0.10-0.36) 0.65 
WRI (%) 5.18 (3.05-7.31) 6.56 (3.24- 9.88) 0.14 
Reservoir-excess pressure analysis 
Peak Pr (mmHg) 6.81 (5.33-8.29) 6.41 (5.36-7.45) 0.46 
Pr integral (mmHgs) 2.34 (1.76-2.92) 2.22 (1.69-2.75) 0.49 
Peak Px (mmHg) 7.52 (5.87-9.17) 8.32 (7.30-9.35) 0.14 
Px integral (mmHgs) 1.29 (0.85-1.73) 1.44 (1.19-1.70) 0.22 
ks (s-1) 10.6 (4.3-16.9) 6.86 (4.86-8.86) 0.16 
kd (s-1) 3.14 (1.45-4.83) 1.70 (0.91-2.49) 0.07 
 (s) 0.47 (0.16-0.78) 0.76 (0.42-0.11) 0.14 
P (mmHg) 7.38 (4.51-10.26) 9.03 (4.21-13.85) 0.55 
ERPI (%) 58.8 (37.2-80.4) 69.7 (49.3-90.1) 0.24 
BW: backward wave (appears as a backward decompression wave in three of the subjects and 
backward compression wave in the rest), ERPI: excess reservoir pressure index, FCW: forward 
compression wave, FDW: forward decompression wave, kd: diastolic rate constant, ks: systolic rate 
constan, PAP: pulmonary arterial pressure, Pr: reservoir pressure (minus diastolic pressure), Px: 
excess pressure, P: asymptotic pressure, : diastolic time constant, U: flow velocity, WRI: wave 
reflection index. *p < 0.05 versus inspiration.  
Table 2: Inspiratory and expiratory data for pulmonary arterial hypertension patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results are presented as mean (95 % CI)  SD or median (25 % – 75 % quartile). Abbreviations: 
BCW: backward compression wave, ERPI: excess reservoir pressure index, FCW: forward 
compression wave, FDW: forward decompression wave, kd: diastolic rate constant, ks: systolic rate 
constant, PAP: pulmonary arterial pressure, Pr: reservoir pressure (minus diastolic pressure), Px: 
 Inspiration Expiration p 
Measurements    
Heart rate (min-1) 81 (76- 86) 81 (76-86)  0.26 
Ejection time (ms) 328 (308-347) 332 (314-351) 0.36 
Systolic PAP (mmHg) 73 (62-84)  78 (67-90) <0.01* 
Diastolic PAP (mmHg) 29 (22-36)  35 (29-42) <0.01* 
Mean PAP (mmHg) 44 (36-51) 50 (42-57)  <0.01* 
Mean velocity (cms-1) 21.9 (15.7-28.0) 21.5 (14.9-28.0) 0.26 
Max velocity (cms-1) 42.7 (29.7-55.7) 40.9 (28.6-53.2) 0.12 
Wave intensity analysis 
Wave speed (ms-1) 12.0 (8.1-16.0) 11.6 (7.9-15.2) 0.42 
FCW (103 Jm-2) 7.10 (5.34-8.85) 6.65 (4.92-8.39) 0.04* 
FDW (103 Jm-2) 2.50 (1.63- 3.37) 2.46 (1.65-3.28) 0.82 
BCW (103 Jm-2) 1.77 (1.07- 2.48) 1.71 (1.33-2.09) 0.85 
WRI (%) 25.5 (18.0-33.0) 28.0 (21.1-34.9) 0.56 
Reservoir-excess pressure analysis 
Peak Pr (mmHg) 26.1 (21.3-30.8) 28.3 (23.3-33.2) 0.03* 
Pr integral (mmHgs) 7.92 (6.15-9.69) 8.66 (7.01-10.32) 0.09 
Peak Px (mmHg) 23.0 (18.8-27.3) 22.7 (18.4-26.9) 0.59 
Px integral (mmHgs) 4.47 (3.47-5.47) 4.37 (3.46-5.29) 0.54 
ks (s-1) 10.9 (8.9-12.8) 11.5 (9.6-13.3) 0.35 
kd (s-1) 5.09 (3.38-6.80) 4.79 (3.53-6.05) 0.29 
 (s) 0.24 (0.15-0.32) 0.24 (0.16-0.32) 0.36 
P (mmHg) 28.8 (22.1-35.5) 33.0 (26.4-39.5) <0.01* 
ERPI (%) 59.4 (44.7-74.2) 51.7 (41.9-61.4) 0.08 
excess pressure, P: asymptotic pressure, : diastolic time constant, U: flow velocity, WRI: wave 
reflection index. * p < 0.05 versus inspiration.   
Table 3: Pressure and velocity measurements and wave intensity parameters during dynamic 
stress tests  
 PAH Control   
Baseline 
p Control  
Valsalva 
p Control  
Handgrip 
p 
Measurements         
Heart rate (min-1) 81 (76-86) 73 (68-78) 0.03* 78 (63-93) 0.30 85 (77-93) <0.01† 
Ejection time (ms) 331 (311-352) 352 (321-383) 0.21 312 (283-341) 0.03† 346 (329-363) 0.56 
sPAP (mmHg) 76 (65-87) 26 (23-28) <0.01* 39 (32-47) 0.01† 27 (24-31) 0.11 
dPAP (mmHg) 33 (27-40) 12 (10-14) <0.01* 31 (23-39) <0.01† 15 (12-18) 0.01† 
PAPm (mmHg) 47 (40-54) 17 (15-19) <0.01* 34 (26-42) <0.01† 20 (17-23) 0.01† 
Umean (cms-1) 21.0 (14.6-27.3) 33.8 (24.5-43.2) 0.02* 24.8 (16.5-33.0) 0.09 35.6 (28.6-42.5) 0.30 
Umax (cms-1) 40.9 (28.6-53.1) 63.0 (47.9-78.1) 0.01* 45.3 (32.9-57.7) 0.02† 62.8 (48.8-76.8) 0.91 
Wave intensity analysis          
Wave speed (ms-1) 12.4 (8.4-16.3) 2.52 (1.96-3.09) <0.01* 2.22 (1.67- 2.77) 0.09 2.68 (2.12-3.23) 0.20 
FCW (103 Jm-2) 6.75 (4.96-8.54) 3.92 (2.55-5.29) 0.01* 2.17 (1.11-2.23) 0.03† 2.85 (2.09-3.61) 0.01† 
FDW (103 Jm-2) 2.42 (1.64-3.21) 1.48 (0.85-2.10) 0.05 1.03 (0.32-1.75) 0.06 1.15 (0.83-1.48) 0.06 
BW (103 Jm-2) 1.72 (1.31-2.13) 0.23 (0.10-0.35) <0.01* 0.11 (-0.02-0.25) 0.02† 0.10 (0.04-0.16) 0.05 
WRI (%) 27.4 (20.7-34.0) 7.01 (3.40-10.62) <0.01* 4.72 (0.60-8.84) 0.32 4.88 (0.93-8.82) 0.14 
 
Results are presented as mean (95 % CI)   SD or median (25 % – 75 % quartile). Abbreviations: 
PAP: pulmonary arterial pressure, FCW: forward compression wave, FDW: forward decompression 
wave, BW: backward wave. *p < 0.05 versus PAH. †p < 0.05 versus baseline.  
  
Table 4: Reservoir parameters for PAH patients and control subjects at rest and during 
dynamic stress tests 
 PAH Control   
Baseline 
p Control  
Valsalva 
p Control  
Handgrip 
p 
Peak Pr (mmHg) 27.0 (22.1-31.9) 6.35 (5.35-7.34) <0.01* 4.42 (3.64-5.20) 0.03† 6.91 (4.70-9.12) 0.38 
Pr integral (mmHgs) 7.89 (6.04-9.75) 2.19 (1.67-2.70) <0.01* 1.71 (1.16-2.26) 0.23 2.37 (1.54-3.20) 0.47 
Peak Px (mmHg) 24.2 (17.5-31.0) 8.44 (7.44-9.45) <0.01* 6.01 (4.27-7.74) <0.01† 7.58 (6.34-8.81) 0.28 
Px integral (mmHgs) 4.27 (3.37-5.26) 1.53 (1.27-1.79) <0.01* 0.95 (0.54-1.36) <0.01† 1.31 (0.96-1.66) 0.21 
ks (s-1) 11.5 (9.7-13.4) 6.55 (4.92-8.17) <0.01* 7.13 (3.99-10.28) 0.35 9.35 (4.59-14.12) 0.20 
kd (s-1) 5.01 (3.68-6.33) 1.58 (1.12-2.04) <0.01* 1.41 (-0.05-2.88) 0.87 2.17 (1.29-3.06) 0.05† 
 (s) 0.24 (0.15-0.32) 0.70 (0.50-0.90) <0.01* 1.43 (0.52-2.33) 0.11 0.64 (0.24-1.05) 0.05 
P (mmHg) 33.2 (26.2-40.2) 8.53 (4.67-12.40) <0.01* 20.9 (5.9-35.8) 0.03† 11.5 (7.5-15.5) 0.09 
ERPI (%) 58.1 (42.3-73.9) 76.3 (50.4-102.2) 0.17 56.7 (36.9-76.5) 0.17 63.0 (40.5-85.5) 0.28 
 
Results are presented as mean (95 % CI)  SD or median (25 % – 75 % quartile). Abbreviations: 
ERPI: excess reservoir pressure index, kd: diastolic rate constant, ks: systolic rate constant, PAH: 
pulmonary arterial hypertension, Pr: reservoir pressure (minus diastolic pressure), Px: excess 
pressure, P: asymptotic pressure, : diastolic time constant. *p < 0.05 versus PAH. †p < 0.05 
versus baseline.  
  
 Figure legends 
Figure 1. Pressure and velocity recording from a representative control subject 
ECG-derived respiratory signal (A) is based on the respiratory variation in the R–S amplitude and 
corresponds temporally to the respiratory variation in pulmonary pressure (B) and flow velocity (C). 
  
  
Figure 2. Wave intensity pattern 
Ensemble-averaged pressure (P, black line) and flow velocity (U, green line) and wave intensity for 
a representative control subject at baseline (A), during Valsalva manoeuvre (B) and during handgrip 
exercise (C) are shown. There is a forward compression wave (FCW, dark blue) associated with 
right ventricular ejection and a forward decompression wave (FDW, light blue) related to 
ventricular relaxation, while there was minimal backward travelling wave present. The magnitude 
of FCW decreased during dynamic stress tests, the time interval between FCW and FDW was 
reduced during Valsalva manoeuvre as a result of shorter ejection period and the cardiac duration 
decreased during handgrip exercise.  
 Figure 3. Arterial wave energy 
Wave energy of the forward compression wave was greater in inspiration compared to expiration in 
both controls (A) and patients with pulmonary arterial hypertension (PAH, B). *p < 0.05.  
 Figure 4. Reservoir-excess pressure analysis 
The reservoir-excess pressure model is illustrated in A. The measured pressure was separated into a 
reservoir pressure and an excess pressure in a representative control subject (B, upper panel) and a 
patient with pulmonary arterial hypertension (PAH, C, upper panel). Both the reservoir and excess 
pressures increased in PAH (note the scale difference). In the lower panel of B and C, the excess 
pressure (black line) was compared to the flow velocity profile (green line, scaled so that the peak 
of the waveforms coincide).  
  
 Figure 5: Relationship between diastolic time constants  and RCTPR 
 is the inverse of the diastolic rate constant and RCTPR is product of total pulmonary vascular 
resistance and compliance. PAH: pulmonary arterial hypertension.  
 
 
 
